AGP Picks
View all

California Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Health Watch.

Press releases published on September 8, 2026

PDS Biotech Announces up to $22.55 Million Financing Led by Dr. Patrick Soon-Shiong, Founder of NantWorks
CRISPR Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
Surrozen Announces Submission of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema
A Micro-Cap Biotech Just Cleared a Milestone Most Never Reach
Can-Fite Reports Q2 2026 Financial Results and Ongoing Clinical Progress Highlighting Longer-Than-Anticipated Overall Survival in Ongoing Pivotal Phase III Liver Cancer Study
Veru Advances Oral Sabizabulin Following Positive Preclinical Data Showing Potent Anticancer Activity in Human Daraxonrasib (Revolution Medicines’ RASONQUE™) Resistant Pancreatic Cancer into a Planned Phase 2 Clinical Trial
GRI Bio Presents New Phase 2a Data at ERS 2026 Defining GRI-0621's Mechanism of Action in IPF Across Nine Mechanistic Pillars
Dr. Gillian Cannon Joins Lindus Therapeutics’ Board as a Non-Executive Director
CPTx appoints Matt Kane as Chief Financial Officer
Renexxion to Present at H.C. Wainwright 28th Annual Global Investment Conference
Avalyn to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
Ibogaine and the Bicameral Mind: The Definitive Clinical and Cultural Guide to Ibogaine Publishes Today
Calidi Biotherapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
QualTex Laboratories adds ISO/IEC 17025 accreditation for microbiology in San Antonio, Atlanta
Collegium to Participate in Upcoming Investor Conferences
Walden Biosciences to Participate in 24th Annual Morgan Stanley Global Healthcare Conference
Vaxart to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Hyperion DeFi Raises Guidance and Announces $20M Share Repurchase Program
Eupraxia Pharmaceuticals Completes Transfer to the Nasdaq Global Select Market and Announces Participation in Upcoming Investor Conferences
Flare Therapeutics Appoints Peter Lebowitz, MD, PhD, to Board of Directors and Brian DeSchuytner as Chief Financial Officer and Chief Business Officer

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

California Health Watch

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.